CS
Comerica Securities Portfolio holdings
AUM
$1.2B
1-Year Return
16.58%
This Quarter Return
+3.98%
1 Year Return
+16.58%
3 Year Return
+25.63%
5 Year Return
+49.47%
10 Year Return
+131.6%
AUM
$723M
AUM Growth
+$49.8M
(+7.4%)
Cap. Flow
+$26.7M
Cap. Flow
% of AUM
3.7%
Top 10 Holdings %
Top 10 Hldgs %
22.87%
Holding
413
New
29
Increased
206
Reduced
142
Closed
17
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
$3.56M |
| 2 |
Gilead Sciences
GILD
|
$3.08M |
| 3 |
Emerson Electric
EMR
|
$3.01M |
| 4 |
Pfizer
PFE
|
$2.97M |
| 5 |
Wells Fargo
WFC
|
$2.73M |
Top Sells
| 1 |
Encompass Health
EHC
|
$3.3M |
| 2 |
DFT
DuPont Fabros Technology Inc.
DFT
|
$2.86M |
| 3 |
INN
Summit Hotel Properties
INN
|
$2.83M |
| 4 |
Tapestry
TPR
|
$2.67M |
| 5 |
Capital One
COF
|
$2.45M |
Sector Composition
| 1 | Healthcare | 6.8% |
| 2 | Financials | 6.79% |
| 3 | Technology | 5.85% |
| 4 | Industrials | 4.93% |
| 5 | Energy | 4.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Target
TGT
$42.3B
| $356K | 0.05% |
6,040
-66
| -1% | -$3.89K |
|
302
Biogen
BIIB
$20.6B
| $353K | 0.05% |
1,126
| – | – |
|
303
Palo Alto Networks
PANW
$130B
| $351K | 0.05% |
14,610
+4,836
| +49% | +$116K |
|
304
Becton Dickinson
BDX
$55.1B
| $348K | 0.05% |
1,822
-50
| -3% | -$9.55K |
|
305
Bristol-Myers Squibb
BMY
$96B
| $342K | 0.05% |
5,359
-39
| -0.7% | -$2.49K |
|
306
Kinder Morgan
KMI
$59.1B
| $339K | 0.05% |
17,686
-3,981
| -18% | -$76.3K |
|
307
iShares Short Treasury Bond ETF
SHV
$20.8B
| $339K | 0.05% |
3,069
-222
| -7% | -$24.5K |
|
308
Dentsply Sirona
XRAY
$2.92B
| $336K | 0.05% |
5,607
+2,018
| +56% | +$121K |
|
309
Nasdaq
NDAQ
$53.6B
| $331K | 0.05% |
12,813
+2,877
| +29% | +$74.3K |
|
310
Vanguard Materials ETF
VAW
$2.89B
| $329K | 0.05% |
2,544
+494
| +24% | +$63.9K |
|
311
Sumitomo Mitsui Financial
SMFG
$105B
| $327K | 0.05% |
42,376
+1,298
| +3% | +$10K |
|
312
Stryker
SYK
$150B
| $323K | 0.04% |
2,271
-50
| -2% | -$7.11K |
|
|
WBA
313
DELISTED
Walgreens Boots Alliance
WBA
| $320K | 0.04% |
4,138
-120
| -3% | -$9.28K |
|
314
Core Laboratories
CLB
$592M
| $318K | 0.04% |
3,221
+461
| +17% | +$45.5K |
|
315
Automatic Data Processing
ADP
$120B
| $315K | 0.04% |
2,864
| – | – |
|
316
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$4.61B
| $315K | 0.04% |
5,416
+12
| +0.2% | +$698 |
|
317
Philips
PHG
$26.5B
| $313K | 0.04% |
9,654
+154
| +2% | +$4.99K |
|
318
UBS Group
UBS
$128B
| $313K | 0.04% |
18,226
+949
| +5% | +$16.3K |
|
319
VanEck Intermediate Muni ETF
ITM
$1.95B
| $311K | 0.04% |
+6,460
| New | +$311K |
|
|
AGN
320
DELISTED
Allergan plc
AGN
| $310K | 0.04% |
1,512
+96
| +7% | +$19.7K |
|
321
WPP
WPP
$5.83B
| $301K | 0.04% |
3,246
-575
| -15% | -$53.3K |
|
322
First Trust Financials AlphaDEX Fund
FXO
$2.23B
| $300K | 0.04% |
10,095
-235
| -2% | -$6.98K |
|
323
Maximus
MMS
$4.97B
| $299K | 0.04% |
4,631
+629
| +16% | +$40.6K |
|
324
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.24B
| $298K | 0.04% |
+10,018
| New | +$298K |
|
|
RDS.B
325
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $298K | 0.04% |
4,760
-339
| -7% | -$21.2K |
|